Story
Intel-Backed Chipmaker Altera Files for U.S. Initial Public Offering
Summary
Altera, a maker of field-programmable gate arrays, has confidentially submitted a draft registration with the SEC. The move comes one year after Intel spun off the unit in a deal with private equity firm Silver Lake.
Altera Corporation, the programmable chipmaker backed by Intel and private equity firm Silver Lake, has confidentially submitted a draft registration statement with the U.S. Securities and Exchange Commission for a proposed initial public offering. The filing marks a swift return to the public markets for the company, which was carved out of Intel just one year ago.
The Proposed Offering
According to the announcement, Altera has filed a Form S-1 registration statement. Key details of the IPO, including the number of common shares to be offered and the potential price range, have not yet been determined.
The timing of the stock market debut remains subject to the SEC's review process and prevailing market conditions. This confidential filing allows the company to begin the IPO process while keeping sensitive financial information private during the initial stages.
Strategic Context and Ownership
The IPO is a pivotal step for both Altera and its parent company, Intel. For Intel, the listing advances a broader corporate restructuring aimed at divesting non-core assets to raise capital for its core foundry and CPU businesses. Intel originally acquired Altera in 2015 for approximately $16.7 billion.
AdLast year, Intel sold a 51% controlling stake to private equity firm Silver Lake in a transaction that valued Altera at $8.75 billion. Intel retained a 49% minority holding, with Middle Eastern state fund MGX also joining as a co-investor. The public offering will allow Intel to further realize value from its remaining stake.
Market Position in FPGAs
Altera is positioning itself to become the largest pure-play provider of field-programmable gate arrays (FPGAs). These are advanced semiconductor chips that can be reprogrammed by customers after manufacturing to suit specific computational needs.
This flexibility makes FPGAs critical components in rapidly evolving sectors. The company is targeting high-growth markets including:
- Artificial intelligence (AI) infrastructure
- Industrial automation and robotics
- Defense systems
Read next
More on Stocks
BOJ Rate Hike Nears, Pitting Japanese Financials Against Exporters
The Bank of Japan is widely expected to raise its key interest rate to a 31-year high this week, a move that is creating a sharp divide in the stock market between beneficiaries like banks and sectors facing pressure, such as exporters.
Genscript Biotech Stock Surges Over 16% on Eli Lilly AI Partnership
Shares in the Hong Kong-listed biotech firm rallied after announcing a collaboration with Eli Lilly's AI-powered drug discovery platform, a move supported by a recent capital raise focused on AI infrastructure.
Volkswagen's Seat Brand Faces Discontinuation Amid Chinese EV Pressure
Volkswagen is reportedly set to phase out its historic Spanish brand, Seat, as part of a major restructuring to combat rising competition from Chinese automakers and focus investment on its profitable, all-electric Cupra marque.
Hong Kong Biotech Sector Shows Stark Divide as Biocytogen, Genscript Post Major Gains
A small group of companies, led by Biocytogen Pharmaceuticals and Genscript Biotech, have delivered substantial one-year returns, highlighting a sharp performance gap within Hong Kong's 52-stock biotech universe where most firms remain unprofitable.